Bexarotene
Bexarotene gel 1% is indicated for the topical treatment of cutaneous lesions in patients with CTCL (Stage IA and IB) who have refractory or persistent disease after other therapies or…
Reliable Prescription Medication Information from RxDrugLabels.com
Find the latest prescription medication package inserts and labels directly from the approved FDA repository of SPL records, keep up with an RSS feed of all FDA prescription medication updates, or follow a company-specific feed of prescription medication updates from an individual manufacturer.
Recently Updated Prescription Medication Labels and Package Inserts
KISQALI (Ribociclib)
KISQALI is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer…
Mesalamine
Mesalamine extended-release capsules are indicated for the induction of remission and for the treatment of adult patients with mildly to moderately active ulcerative colitis…
KISQALI FEMARA CO-PACK (Letrozole and Ribociclib)
The KISQALI FEMARA CO-PACK is indicated as initial endocrine-based therapy for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor…
Lactulose
For the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. Controlled studies have shown that lactulose solution therapy…
And More…
- Femara Novartis Pharmaceuticals Corporation
- Gentamicin Hikma Pharmaceuticals USA Inc.
- Naproxen Sodium PD-Rx Pharmaceuticals, Inc.
- Etodolac Preferred Pharmaceuticals Inc.
- TADALAFIL Torrent Pharmaceuticals Limited
- Galantamine American Health Packaging
- Ranolazine Camber Pharmaceuticals, Inc.
See more of the latest, organized alphabetically…